Current Research
Funding for some of the studies has been provided by the National Institute of Mental Health, the National Alliance for Research on Schiophrenia and Depression, the American Psychological Association, pharmaceutical companies, other industries, and private donors. Please contact Dr. Hofmann at 617 353 9233 or shofmann@bu.edu for any inquiries or questions about funding or donations.
The Usage of D-Cycloserine to Enhance CBT for Social Anxiety Disorder
This NIMH-funded study examines the effects of d-cycloserine to enhance the efficacy of CBT for social anxiety disorder. The trial is currently enrolling participants. Please contact (617) 353-9610 for more information.
This study is registered at the US Clinical Trials Registry, located at http://clinicaltrials.gov/ct2/show/NCT00515879?term=Hofmann&rank=1
Psychophysiological and Neurobiological Correlates of CBT for Social Anxiety Disorder
We have been conducting a series of studies examining the psychophysiological and neurobiological changes that occur as a result of CBT for social anxiey disorder.
CBT of Prodromal Schizophrenia
This study examines the efficacy of CBT to prevent the onset of schizophrenia in high-risk individuals and its associated neurobiological and genetic factors.
